| Literature DB >> 30165629 |
Thomas J Stocker1,2, Simon Deseive1,2, Jonathon Leipsic3, Martin Hadamitzky4, Marcus Y Chen5, Ronen Rubinshtein6, Mathias Heckner1, Jeroen J Bax7, Xiang-Ming Fang8, Erik Lerkevang Grove9, John Lesser10, Pál Maurovich-Horvat11, James Otton12, Sanghoon Shin13, Gianluca Pontone14, Hugo Marques15, Benjamin Chow16, Cesar H Nomura17, Ramzi Tabbalat18, Axel Schmermund19, Joon-Won Kang20, Christopher Naoum21, Melany Atkins22, Eugenio Martuscelli23, Steffen Massberg1,2, Jörg Hausleiter1,2.
Abstract
Aims: Advances of cardiac computed tomography angiography (CTA) have been developed for dose reduction, but their efficacy in clinical practice is largely unknown. This study was designed to evaluate radiation dose exposure and utilization of dose-saving strategies for contrast-enhanced cardiac CTA in daily practice. Methods and results: Sixty one hospitals from 32 countries prospectively enrolled 4502 patients undergoing cardiac CTA during one calendar month in 2017. Computed tomography angiography scan data and images were analysed in a central core lab and compared with a similar dose survey performed in 2007. Linear regression analysis was performed to identify independent predictors associated with dose. The most frequent indication for cardiac CTA was the evaluation of coronary artery disease in 89% of patients. The median dose-length product (DLP) of coronary CTA was 195 mGy*cm (interquartile range 110-338 mGy*cm). When compared with 2007, the DLP was reduced by 78% (P < 0.001) without an increase in non-diagnostic coronary CTAs (1.7% in 2007 vs. 1.9% in 2017 surveys, P = 0.55). A 37-fold variability in median DLP was observed between the hospitals with lowest and highest DLP (range of median DLP 57-2090 mGy*cm). Independent predictors for radiation dose of coronary CTA were: body weight, heart rate, sinus rhythm, tube voltage, iterative image reconstruction, and the selection of scan protocols.Entities:
Mesh:
Year: 2018 PMID: 30165629 PMCID: PMC6455904 DOI: 10.1093/eurheartj/ehy546
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983